2024 perioperative management glp-1 receptor agonists anesthesia Glucagon-Like Peptide-1 in Care Glucagon-Like Peptide 1 Receptor Agonists

New analyses involving more than 100,000 patients suggest that users of popular diabetes and weight-loss medications face a lower risk of developing certain cancers and a reduced risk of metastasis.

Increase Dietary Fiber Intake Fiber, especially soluble fiber, is one of the most effective natural glp 1 agonists

For people who stopped taking GLP-1 weight-loss medications, patients regained about 60% of the weight []

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.

Pharmacovigilance analyses identified disproportionate reporting signals for dyspnoea and asthma-like events, particularly with exenatide, using the reporting odds ratio (ROR 2.14, 95% CI 1.882.43

#GLP1 #DiabetesCare #ObesityManagement #PharmaIndustry #ClinicalResearch #DrugDevelopment #HealthcareInnovation #Endocrinology #Biotech #RegulatoryAffairs